TherOx Cancels IPO

TherOx Inc., an Irvine, Calif.-based developer of devices for cardiac ischemia patients, has withdrawn registration for a $100 million IPO. It had planned to trade on the Nasdaq, with Citi and UBS serving as co-lead underwriters. The company has raised over $120 million in total VC funding since 1995, including a $30 million Series J round earlier this year. Backers include Kleiner Perkins Caufield & Byers (27.8% pre-IPO stake), Integral Capital Partners (14.5%), New Science Ventures (14.8%) and Aperture Venture Partners (10.5%).

Leave a Reply

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget